A new study has revealed that testosterone therapy might prove to be an effective treatment for obesity in men. Experts say that long-term testosterone therapy can be more beneficial as compared to weight loss surgery for men. They claim that testosterone treatment has a low risk of complications as well. In the study, Experts have seen that obesity treatment with testosterone has reduced the body mass by 20 percent on average. The US Center for Disease Control and Prevention (CDC) says that nearly 42 percent of adults deal with obesity in the US. As per the experts, obesity can trigger other chronic health issues as well including heart diseases, and type 2 diabetes. Recent studies have shown that obesity can lead to major complications if it is linked with COVID19 infection. It has prompted state governments to introduce new public health strategies to push people to lose weight.
A pharmaceutical company Bayer and Gulf Medical University in UAE have conducted the study. Experts have used the data from the last 11 years. They have looked at the data of 471 men with hypogonadism and obesity since 2004. Hypogonadism is a condition, which is linked to low testosterone production. Nearly 58 percent of men have been given testosterone injection every 3 months during the study. Other participants have not been given the dose of testosterone. They have been kept as a control group. The average age of participants has been 61.5 years. There have been no dropouts during the study. Experts have revealed that people who have been given testosterone injections have lost around 23 kgs during the study. While others who have not received the same treatment have gained another six pounds.
Experts have seen that there has been a decline of 7.6 points in the body mass index of people who have received testosterone infection, at the same time; there has been an increase of 2 points among the control group. The waist circumference of people who have been treated with testosterone has reduced by an average of 13 centimeters while it has increased by 7 centimeters among the people in the control group. An increased volume of the waist circumference is considered as a risk factor for cardiometabolic ailments as well. Largely, people who have received testosterone shots have been at low risk of cardiovascular diseases, while 28 percent of people from the control group have suffered a heart attack during the study. Around 27.2 percent of participants from the control group have suffered a stroke as well. Similarly, nearly 20 percent of people from the control group have developed type 2 diabetes during the study.